These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11187876)

  • 1. Risk factors for inhibitor development in hemophilia A.
    Oldenburg J; Brackmann HH; Schwaab R
    Haematologica; 2000 Oct; 85(10 Suppl):7-13; discussion 13-4. PubMed ID: 11187876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between factor VIII genotype and inhibitor development in hemophilia A.
    Fakharzadeh SS; Kazazian HH
    Semin Thromb Hemost; 2000; 26(2):167-71. PubMed ID: 10919409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII.
    Oldenburg J; Picard JK; Schwaab R; Brackmann HH; Tuddenham EG; Simpson E
    Thromb Haemost; 1997 Feb; 77(2):238-42. PubMed ID: 9157573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilia A: mutation type determines risk of inhibitor formation.
    Schwaab R; Brackmann HH; Meyer C; Seehafer J; Kirchgesser M; Haack A; Olek K; Tuddenham EG; Oldenburg J
    Thromb Haemost; 1995 Dec; 74(6):1402-6. PubMed ID: 8772209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
    Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
    Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.
    Gouw SC; Van Der Bom JG; Van Den Berg HM; Zewald RA; Ploos Van Amstel JK; Mauser-Bunschoten EP
    Haemophilia; 2011 Mar; 17(2):275-81. PubMed ID: 21070499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
    Astermark J; Oldenburg J; Escobar M; White GC; Berntorp E;
    Haematologica; 2005 Jul; 90(7):924-31. PubMed ID: 15996930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J; Pavlova A
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses.
    Liu ML; Nakaya S; Thompson AR
    Thromb Haemost; 2002 Feb; 87(2):273-6. PubMed ID: 11858487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors.
    Lee CA; Lillicrap D; Astermark J
    Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():10-4. PubMed ID: 16804830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.
    Coppola A; Santoro C; Tagliaferri A; Franchini M; DI Minno G
    Haemophilia; 2010 Jan; 16 Suppl 1():13-9. PubMed ID: 20059564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
    Astermark J
    Haemophilia; 2006 Jul; 12 Suppl 3():52-60. PubMed ID: 16683997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of factor VIII inhibitors.
    Hay CR
    Haemophilia; 2006 Dec; 12 Suppl 6():23-8; discussion 28-9. PubMed ID: 17123390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions.
    Jayandharan G; Shaji RV; Baidya S; Nair SC; Chandy M; Srivastava A
    Haemophilia; 2005 Sep; 11(5):481-91. PubMed ID: 16128892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development.
    Goodeve AC; Peake IR
    Semin Thromb Hemost; 2003 Feb; 29(1):23-30. PubMed ID: 12640561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Description of 62 novel mutations.
    Vinciguerra C; Zawadzki C; Dargaud Y; Pernod G; Berger C; Nougier C; Négrier C
    Thromb Haemost; 2006 Apr; 95(4):593-9. PubMed ID: 16601827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks.
    Rossetti LC; Szurkalo I; Radic CP; Abelleyro MM; Primiani L; Neme D; Candela M; Bianco RP; de Tezanos Pinto M; Larripa IB; De Brasi CD
    Haemophilia; 2013 Jul; 19(4):511-8. PubMed ID: 23534532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.